Indivior PLC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
INDV
Indivior PLCSCHEDULE: Oaktree Funds Exit Indivior Stake
Oaktree-managed funds have significantly reduced their holdings in Indivior Pharmaceuticals, Inc., indicating a potential exit from their investment.
NASDAQ
INDV
Indivior PLCSCHEDULE: Oaktree Reduces Indivior Stake to 5.69%
Oaktree Capital Management and its affiliates have significantly reduced their beneficial ownership in Indivior PLC, selling over 1.6 million shares in December 2025.
NASDAQ
INDV
Indivior PLCTwo Seas Capital LP and its affiliates have reduced their beneficial ownership in Indivior PLC to 4.98%, falling below the 5% reporting threshold.
NASDAQ
INDV
Indivior PLCTwo Seas Capital LP and its affiliates have reduced their beneficial ownership in Indivior PLC to 5.7% through a series of open market transactions.
NASDAQ
INDV
Indivior PLCSCHEDULE: Oaktree Reduces Indivior Stake to 7%
Oaktree Capital Management and its affiliates have reduced their beneficial ownership in Indivior PLC to 7.0% through a series of share sales.
NASDAQ
INDV
Indivior PLCTwo Seas Capital LP and affiliates updated their Schedule 13D filing for Indivior PLC, disclosing a 7.4% beneficial ownership and recent trading activity including significant share sales.
NASDAQ
INDV
Indivior PLCTwo Seas Capital LP and affiliates filed an Amendment No. 10 to their Schedule 13D, reporting a beneficial ownership of 8.3% in Indivior PLC after significant share sales.
NASDAQ
INDV
Indivior PLCTwo Seas Capital LP and its affiliates have filed Amendment No. 9 to their Schedule 13D, disclosing a 9.3% beneficial ownership in Indivior PLC and recent trading activity that resulted in a net reduction of shares.
NASDAQ
INDV
Indivior PLCTwo Seas Capital LP and its affiliates have filed an Amendment No. 8 to their Schedule 13D, revealing a continued 9.7% beneficial ownership in Indivior PLC, alongside recent share transactions and financing arrangements.
NASDAQ
INDV
Indivior PLCSCHEDULE 13D/A: Two Seas Capital Amends Indivior PLC Stake Disclosure, Repays $7 Million Credit Facility
Two Seas Capital LP and its affiliates have filed an Amendment No. 7 to their Schedule 13D, updating their beneficial ownership in Indivior PLC to 9.7% and disclosing the repayment of a $7 million credit facility.
NASDAQ
INDV
Indivior PLCSCHEDULE 13D/A: Two Seas Capital Increases Indivior PLC Stake to 9.5% with Leveraged Investment and Swaps
Two Seas Capital LP and its affiliates have updated their Schedule 13D filing, revealing a 9.5% beneficial ownership in Indivior PLC, financed through working capital and a credit facility, alongside new cash-settled swap agreements.
NASDAQ
INDV
Indivior PLCOaktree Parties have increased their beneficial ownership in Indivior PLC to 8.6% and entered into an Amended and Restated Relationship Agreement, granting them significant influence over the company's board composition and governance.
NASDAQ
INDV
Indivior PLCTwo Seas Capital LP and its affiliates have filed an Amendment No. 5 to their Schedule 13D, disclosing a 9.3% beneficial ownership in Indivior PLC, alongside details of a significant credit facility and cash-settled swap agreements.
NASDAQ
INDV
Indivior PLCSCHEDULE 13D/A: Two Seas Capital Amends Indivior PLC Stake, Discloses Pledged Shares and Credit Facility Details
Two Seas Capital LP has filed Amendment No. 4 to its Schedule 13D for Indivior PLC, detailing its continued 9.6% beneficial ownership, the pledging of shares under a UBS credit facility, and recent trading activities.